Caffeinol at the receptor level: Anti-ischemic effect of n-methyl-d-aspartate receptor blockade is potentiated by caffeine

Stroke

Volumn 41, Issue 2, 2010, Pages 363-367

  Zhao, Xiurong ^a   Strong, Roger ^a   Piriyawat, Paisith ^a   Palusinski, Robert ^a   Grotta, James C ^a   Aronowski, Jaroslaw ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Caffeine; Ethanol; Excitotoxicity; Magnesium; Neuroprotection; NMDA antagonist

Indexed keywords

ALCOHOL; APTIGANEL; CAFFEINE; CAFFEINOL; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; DIZOCILPINE MALEATE; GUANIDINE DERIVATIVE; N METHYLASPARTIC ACID; NEUROTOXIN; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTI ISCHEMIC EFFECT; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; EXCITOTOXICITY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMBINATION; METABOLISM; NERVE DEGENERATION; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; TIME; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; CAFFEINE; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; ETHANOL; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GUANIDINES; MALE; N-METHYLASPARTATE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77449095409     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.562900     Document Type: Article

References (19)

1. Aronowski J, Strong R, Shirzadi A, Grotta JC. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke. 2003;34:1246-1251. (Pubitemid 36547523)
2. Strong R, Grotta JC, Aronowski J. Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Neuropharmacology. 2000;39:515-522.
3. Belayev L, Khoutorova L, Zhang Y, Belayev A, Zhao W, Busto R, Ginsberg MD. Caffeinol confers cortical but not subcortical neuroprotection after transient focal cérébral ischemia in rats. Brain Res. 2004; 1008:278-283.
4. Dash PK, Moore AN, Moody MR, Treadwell R, Felix JL, Clifton GL. Post-trauma administration of caffeine plus ethanol reduces contusion volume and improves working memory in rats. J Neurotrauma. 2004;21: 1573-1583.
5. Piriyawat P, Labiche LA, Burgin WS, Aronowski JA, Grotta JC. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Stroke. 2003;34:1242-1245.
6. Dildy JE, Leslie SW. Ethanol inhibits NMDA-induced increases in free intracellular ca2+ in dissociated brain cells. Brain Res. 1989;499: 383-387.
7. Lovinger DM, White G, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 1989;243:1721-1724.
8. Chandler LJ, Sumners C, Crews FT. Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol Clin Exp Res. 1993;17:54-60.
9. Fredholm BB. Astra award lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995;76:93-101.
10. Zhao X, Ou Z, Grotta JC, Waxham N, Aronowski J. Peroxisome-proliferator- activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity. Brain Res. 2006;1073-1074: 460-469.
11. Aronowski J, Strong R, Grotta JC. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 1997;17:1048-1056.
12. Aronowski J, Cho KH, Strong R, Grotta JC. Neurofilament proteolysis after focal ischemia; when do cells die after experimental stroke? J Cereb Blood Flow Metab. 1999;19:652-660.
13. Aronowski J, Ostrow P, Samways E, Strong R, Zivin JA, Grotta JC. Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats. Stroke. 1994;25:2235-2240.
14. Zhao X, Liu SJ, Zhang J, Strong R, Aronowski J, Grotta JC. Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Stroke. 2005;36:129-134.
15. Group Nr-PSS. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995; 333:1581-1587.
16. Martin-Schild S, Hallevi H, Shaltoni H, Barreto AD, Gonzales NR, Aronowski J, Savitz SI, Grotta JC. Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia. J Stroke Cerebrovasc Dis. 2009;18: 86-96.
17. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399-415.
18. Lovinger DM. Developmental decrease in ethanol inhibition of n-methyl-d-aspartate receptors in rat neocortical neurons: relation to the actions of ifenprodil. J Pharmacol Exp Ther. 1995;274:164-172.
19. Muir KW. Magnesium in stroke treatment. Postgrad Med J. 2002;78: 641-645.